Immune phenotyping based on neutrophil-to-lymphocyte ratio and IgG predicts disease severity and outcome for patients with COVID-19
Detection Principle
ImmunoAssay-Antibody
Target
IgG and IgM
Testing Method Category
Other
Testing Method
Human SARS-CoV-2 IgG and IgM Chemiluminescence Analysis (CLIA) Assays panel (Shenzhen YHLO Biotech Co.,Ltd., Shenzhen, China)
Testing Method - Additional Info
Investigation of disease severity due to robust antibodies production
Reported Performance
Severe cases were found in: Neutrophil-to-lymphocytes ratio (NLR) NLR high and IgG high: 72.3%; NLR high and IgG low: 48.5%; NLRlow and IgG high: 33.3%, NLR low and IgG low: 15.6%
Sample Size
222 patients
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements